January 23-24, 2016

FORT LAUDERDALE MARRIOTT
HARBOR BEACH RESORT & SPA

3030 Holiday Drive
Fort Lauderdale, FL 33316


Only practicing US and Canadian interventional cardiologists are eligible to participate.
There is no cost to apply.

Sponsored by the Cardiovascular Research Foundation
Supported through a grant from ABIOMED, Inc.

Overview

Cardiogenic shock is present in 32% of patients who die within the first 30 days post-PCI and occurs in about 7% of all patients undergoing PCI. PCI is the only known treatment that improves mortality rates for STEMI patients with cardiogenic shock. Hemodynamic support devices, including intra-aortic balloon pumps and ventricular assist devices, are institutional requirements for PCI competence and integral to providing a safe and effective environment for PCI operators. This day and a half program will include case presentations, panel discussions of submitted cases, and didactic presentations covering the latest data and devices for hemodynamic support.

Learning Objectives

By the end of this program, the attendees will be able to:

  • Analyze hemodynamic support strategies in high-risk patients ineligible for surgery.
  • Compare evidence for percutaneous mechanical circulatory support devices in cardiogenic shock.
  • Discuss cases where percutaneous ventricular assist devices (PVADs) were used.
  • Identify tips and tricks for reducing complications and managing circulatory support devices.
This educational activity is designed for practicing US and Canadian interventional cardiologists and clinical cardiologists involved in the management of patients with cardiovascular disease requiring hemodynamic support.
Evaluation by questionnaire will address content, presentation effectiveness, possible bias, and future educational needs.
Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation or the course directors of this activity.
This program is sponsored by the Cardiovascular Research Foundation and supported through a grant from ABIOMED, Inc. The Cardiovascular Research Foundation ensures that its programs are educational and meet the needs of the target audience.
Only practicing US and Canadian interventional cardiologists are eligible to participate. Travel and hotel support will be provided to accepted applicants who fully participate in the program per the acceptance guidelines. There is no cost to apply. This program is not CME accredited.

This activity is not CME accredited, and therefore the supporter is required under the Sunshine Act (as part of the Affordable Care Act) to track and report all payments and transfers of value to US licensed physicians, including meals and expenses that are provided to you. In order to help supporters comply with the Sunshine Act, the names and contact information of all US and Canadian licensed physicians participating in this function will be provided to the supporter of this program. The information provided will be used for reporting purposes only.


Should you partake in this program, you will be reported as part of the Sunshine Act submission and will appear on the CMS Open Payments website on the next reporting cycle.


VERMONT-LICENSED HCPs

Vermont laws prohibit this program from providing any complimentary food, meals, or refreshments to healthcare professionals licensed by and regularly practicing in Vermont. Accordingly, healthcare professionals licensed by and practicing in Vermont are requested not to apply for this program.

CHIP: Hemodynamic Support and Complex PCI

Faculty

CHAIRS


Ajay J. Kirtane, MD, SM New York-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

John M. Lasala, MD, PhD Washington University School of Medicine
St. Louis, MO

Martin B. Leon, MD New York-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

Jeffrey W. Moses, MD New York-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

INVITED FACULTY


Mark B. Anderson, MD Albert Einstein Medical Center
Philadelphia, PA

Daniel Burkhoff, MD, PhD NewYork-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

A. Reshad Garan, MD New York-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

J. Aaron Grantham, MD University of Missouri Kansas-City/
St. Luke’s Mid America Heart Institute
Kansas City, MO

Sanjog Kalra, MD, MSc New York-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

Navin K. Kapur, MD Tufts Medical Center
Boston, MA

Dimitri Karmpaliotis, MD, PhD New York-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

James M. McCabe, MD University of Washington Medical Center
Seattle, WA

Magnus Ohman, MD Duke University Medical Center
Durham, NC

Sunil Rao, MD Durham VA Medical Center/
Duke University Medical Center
Durham, NC

Agenda

Interactive Workshops

12:00 PM

Registration

1:00 PM

Breakout Workshops

Hemodynamic Simulator(ABIOMED, Inc.)

Large Bore Closure Training/Simulator Workshop(Abbott Vascular)

CTO Simulation: Retrograde Models Workshop(Abbott Vascular and Boston Scientific Corporation)

Adjunctive Devices(Boston Scientific Corporation, Cardiovascular Systems, Inc. and Spectranetics)

1:00 PM - 1:45 PM Rotation 1

2:00 PM - 2:45 PM Rotation 2

3:00 PM - 3:45 PM Rotation 3

4:00 PM - 4:45 PM Rotation 4

6:30 PM

Reception

7:00 PM

Open Case Discussions Over Dinner: Roundtable Presentations

9:00 PM

Adjourn

7:00 AM

Breakfast

PART I: INTRODUCTION TO COMPLEX PCI AND HEMODYNAMICS

8:00 AM

Welcome and Course GoalsMartin B. Leon

8:05 AM

Introduction to CHIP and Advanced Shock Therapies: Skill Sets Required (Subspecialization)Ajay J. Kirtane

8:20 AM

The Spectrum of Available Percutaneous Devices for MCSNavin K. Kapur

8:50 AM

Hemodynamics of Cardiac Decompensation and Mechanical Circulatory SupportDaniel Burkhoff

9:05 AM

Break

PART II: INTERACTIVE CASE-BASED DISCUSSIONS

Workshop 1: Hemodynamic Support for the High-Risk, Complex PCI Patient

Moderator: Martin B. Leon
9:30 AM

Case Presentation: Multivessel Disease with CTO and Low Ejection FractionDimitri Karmpaliotis

9:36 AM

Audience Polls: How Would I Treat This Patient in My Institution?

9:45 AM

What Constitutes the “No Surgical Option Patient” and Barriers to Treating These PatientsJames M. McCabe

10:00 AM

What Is an Optimal Strategy for High-Risk Patients? A Look at the EvidenceJeffrey W. Moses

10:15 AM

Moderated Discussion of Case Strategy with Q&A Including Institutional Issues Surrounding Revascularization Decisions

10:27 AM

Audience Poll: Would You Treat the CTO?

10:30 AM

CTO Revascularization in 2015: A Look at the Evidence and How Far We’ve ComeJ. Aaron Grantham

10:45 AM

Technical Aspects of Complex PCI and Revascularization: CTOs, Calcium, Bifurcation, and ImagingDimitri Karmpaliotis

11:05 AM

Audience Response: Does This Patient Need Support During PCI?

11:10 AM

Initiation of MCS: The Right Time, Right Place, Right PatientE. Magnus Ohman

11:30 AM

Testing of Each Response on Harvi Model with Panel Discussion Around the Results of Each Hemodynamic ModelDaniel Burkhoff

11:50 AM

Audience Poll and Synthesis/Discussion

12:00 PM

Case Resolution: What We Did for This PatientDimitri Karmpaliotis

12:15 PM

Lunch Break

Workshop 2: Cardiogenic Shock

Moderators: John M. Lasala, Mark B. Anderson
Discussant: E. Magnus Ohman
1:00 PM

Case Presentation: Cardiogenic ShockSanjog Kalra

1:06 PM

Audience Polls: How Would I Treat This Patient in My Institution?

1:15 PM

Definition of the Syndrome and Goals of Therapy (Including Revascularization)Sunil Rao

1:35 PM

Rationale for MCS and LV Unloading in Cardiogenic ShockNavin K. Kapur

1:55 PM

Audience Poll: MCS for This Case?

2:00 PM

Testing of Each Response on Harvi Model with Panel Discussion Around the Results of Each Hemodynamic ModelDaniel Burkhoff

2:15 PM

Case Presentation: CCU CourseSanjog Kalra

2:22 PM

Audience Poll: What is the Reason for this Patient’s Lack of Improvement?

2:29 PM

Biventricular Shock and the Need for Biventricular SupportA. Reshad Garan

2:50 PM

Audience Poll and Synthesis/Discussion

2:52 PM

Testing of Each Response on Harvi Model with Panel Discussion Around the Results of Each Hemodynamic ModelDaniel Burkhoff

3:07 PM

Case Resolution: What We Did for This PatientSanjog Kalra

3:22 PM

Break

PART III. SPECIAL TOPICS

Moderators: Jeffrey W. Moses, Ajay J. Kirtane
3:30 PM

Tips and Tricks of Patient and Device ManagementJohn M. Lasala

4:00 PM

Top Three Cases with Panel Discussion

4:45 PM

Summary and Conclusions: What Did We Learn?Jeffrey W. Moses

5:00 PM

Adjourn

*Agenda is subject to change.